Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.80 -0.05 (-2.52%)
At close: Aug 20, 2026 · 1:55 PM UTC

Zhengye Biotechnology Holding (ZYBT) Current Leases (2025)

Zhengye Biotechnology Holding (ZYBT) posted quarterly Current Leases of $14945.2 for Q4 2025.

Zhengye Biotechnology Holding (ZYBT) Current Leases (2025) Analysis & Trends

Zhengye Biotechnology Holding (ZYBT) has reported Current Leases for 1 consecutive years, with $14945.2 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Current Leases changed N/A year-over-year to $14945.2; the TTM figure through Dec 2025 stood at $14945.2 (changed N/A YoY), while the FY2025 annual figure was $15000.0, changed N/A from the prior year.
  • Current Leases steadied at $14945.2 in Q4 2025 per ZYBT's latest filing.
  • Across five years, Current Leases topped out at $14945.2 in Q4 2025 and bottomed at $14945.2 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn -
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Zhengye Biotechnology Holding 85.23 Mn 77.91 Mn - 14,945.22

Historic Data

Download Data
DateValue
Dec 31, 2025 14,945.22